Enhancing PD-L1 Degradation by ITCH during MAPK Inhibitor Therapy Suppresses Acquired Resistance is a research paper published in Cancer Discovery (2022). On theSindex it has a DataRank of 0. It has been cited 39 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: 1R01CA176111A1
National Cancer Institute
Grant: 1R21CA215910-01
National Cancer Institute
Grant: R21CA255837-01
National Cancer Institute
Grant: 1P01CA168585
National Institutes of Health
Grant: GM089778
NCI NIH HHS
Grant: R01 CA176111
NCI NIH HHS
Grant: R21 CA255837
NIGMS NIH HHS
Grant: R01 GM089778
NCI NIH HHS
Grant: P01 CA168585
NCI NIH HHS
Grant: P01 CA244118
NCI NIH HHS
Grant: P30 CA016042
NCI NIH HHS
Grant: R21 CA215910
Melanoma Research Alliance
V Foundation for Cancer Research
Influential Citations
1
Fields of Study
MeSH Terms